Skip to main content
Log in

New advanced glycation end-products inhibitors from Dichrostachys cinerea Wight & Arn.

  • Note
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

Free radical scavenging and advanced glycation end-product (AGE) inhibitory potential were evaluated in the crude methanol extract of Dichrostachys cinerea. Bioassay-guided isolation led to the identification of four flavan-3-ols, namely (−)-mesquitol (1), oritin (2), (−)-festidinol (3) and (−)-epicatechin (4). Analysis of structure–activity relationships revealed that the presence of 7,8-dihydroxyl groups in the A-ring of flavan-3-ols in conjunction with 3′,4′-dihydroxyls in the B-ring (1) is an important criterion for displaying potent AGE inhibitory activity along with free radical scavenging properties. (−)-Mesquitol (1), oritin (2), and (−)-festidinol (3) were found to be new natural AGE inhibitors. (−)-Mesquitol (1) displayed the most potent AGE inhibitory activity. Results suggest that (−)-mesquitol (1) may serve as an important natural organic lead compound for future development of antiglycating agents along with potent antioxidant activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Striban A, Tschoepe D, Stratmann B (2009) Shifting the disease management paradigm from glucose: what are the pros? Diabetes Care 32:S349–S352

    Article  Google Scholar 

  2. Meerwaldt R, Links L, Zeebregts C, Tio R, Hillebrands J, Smit A (2008) The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol 7:29

    Article  PubMed  Google Scholar 

  3. Beisswenger PJ, Howell SK, O’Dell RM, Wood ME, Touchette AD, Szwergold BS (2001) α-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 24:726–732

    Article  PubMed  CAS  Google Scholar 

  4. Stirban A, Negrean M, Starmann B, Gawlowski T, Horstmann T, Gotting C, Kleesiek K, Muller-Roesel M, Koschinsky T, Uribarri J, Vlssara H, Tschoepe D (2006) Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2. Diabetes Care 29:2064–2071

    Article  PubMed  CAS  Google Scholar 

  5. Tiwari AK, Rao JM (2002) Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr Sci 83:30–38

    Google Scholar 

  6. Tiwari AK (2004) Antioxidants: new generation therapeutic base for treatment of polygenic disorders. Curr Sci 86:1092–1102

    CAS  Google Scholar 

  7. Yamasaki K, Hishiki R, Kato E, Kawabata J (2011) Study of kaempferol glycoside as an insulin mimic reveals glycon to be the key active structure. ACS Med Chem Lett 2:17–21

    Article  CAS  Google Scholar 

  8. Sharma PV (2006) The classical uses of medicinal plants, (Haridas Ayurveda Series-4, Chankhambha Visvabharathi, Varnasi, India), 1st edn, pp 348–349

  9. Rao RJ, Tiwari AK, Kumar US, Reddy SV, Ali AZ, Rao JM (2003) Novel 3-O-acyl mesquitol analogues as free-Radical scavengers and enzyme inhibitors: synthesis, biological evaluation and structure–activity relationship. Bioorg Med Chem Lett 13:2777–2780

    Article  PubMed  CAS  Google Scholar 

  10. Bennie L, Coetzee J, Malan E, Ferriera D (2002) (4→6)-Coupled proteracacinidins and promelacacinidins from Acacia galpinii and Acacia caffra. Phytochemistry 60:521–532

  11. Foo LY, Hritch L, Vilain C (1985) Phylloflavan, a characteristic constituent of Phyllocladus species. Phytochemistry 24:1495–1498

    Article  CAS  Google Scholar 

  12. Morimoto S, Nonaka GI, Nishioka I, Ezaki N, Takizawa N (1985) Tannins and related compounds. XXIX. Seven new methyl derivatives of flavan-3-ols and a 1,3-diarylpropan-2-ol from Cinnamomum cassia, C. obtusifolium and Lindera umbellata var. membranacea. Chem Pharm Bull 33:2281–2286

    CAS  Google Scholar 

  13. Matsuda H, Wang T, Managi H, Yoshikawa M (2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 11:5317–5323

    Article  PubMed  CAS  Google Scholar 

  14. Sultana N, Choudhary MI, Khan A (2009) Protein glycation inhibitory activities of Lawsonia inermis and its active principles. J Enzyme Inhib Med Chem 24:257–261

    Article  PubMed  CAS  Google Scholar 

  15. Tiwari AK, Swapna M, Ayesha SB, Zehra A, Agawane SB, Madhusudana K (2011) Identification of proglyceamic and antihyperglyceamic activity in antioxidant rich fraction of some common food grains. Int Food Res J 18:883–891

    Google Scholar 

Download references

Acknowledgments

Authors thank Dr. J. S. Yadav, Director, Indian Institute of Chemical Technology for his constant encouragement. This work was financially supported by the grant NWP-0004 from Council of Scientific and Industrial research, New Delhi (India) under CSIR-Network program.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ashok K. Tiwari or K. Suresh Babu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suresh, G., Tiwari, A.K., Radha Krishna Murthy, M. et al. New advanced glycation end-products inhibitors from Dichrostachys cinerea Wight & Arn.. J Nat Med 66, 213–216 (2012). https://doi.org/10.1007/s11418-011-0557-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-011-0557-3

Keywords

Navigation